Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | 0 | 0 | 0 |
Gross profit | — | 0 | 0 | 0 |
Operating expense | ||||
Research & development | — | 10K | 48.8K | 25K |
Selling general and admin | 281.9K | 160.3K | 118.3K | 299.0K |
Other operating expenses | — | — | — | 38.7K |
Operating income | -281.9K | -170.3K | -167.4K | -324.9K |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | 278 | -26.5K | 2.0K |
Pretax income | -281.9K | -170.0K | -193.9K | -322.9K |
Tax provision | — | — | — | — |
Net income | -281.9K | -170.0K | -193.9K | -322.9K |
Basic EPS | 0.0 | — | 0.0 | 0.0 |
Diluted EPS | 0.0 | — | 0.0 | 0.0 |
Basic average shares | 15.6M | — | 13.4M | 12.8M |
Diluted average shares | 15.6M | — | 13.4M | 12.8M |
EBITDA | -281.9K | -170.3K | -140.5K | -324.0K |
Net income from continuing op. | -281.9K | -170.0K | -193.9K | -322.9K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |